TAM
WST icon

Trust Asset Management’s West Pharmaceutical WST Stock Holding History

Trust Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Hold
805
– – 0.02% 201
2026
Q1 		$202K Hold
805
– – 0.01% 223
2025
Q4 		$221K Sell
805
-33
-4% -$9.03K 0.02% 214
2025
Q3 		$220K Buy
+838
New +$204K 0.02% 222
2025
Q1 		– Sell
-853
Closed -$279K – 231
2024
Q4 		$279K Hold
853
– – 0.02% 188
2024
Q3 		$256K Hold
853
– – 0.02% 196
2024
Q2 		$281K Hold
853
– – 0.02% 181
2024
Q1 		$338K Hold
853
– – 0.03% 162
2023
Q4 		$300K Hold
853
– – 0.03% 162
2023
Q3 		$320K Hold
853
– – 0.03% 148
2023
Q2 		$326K Hold
853
– – 0.03% 154
2023
Q1 		$296K Buy
+853
New +$249K 0.03% 163
2022
Q4 		– Sell
-839
Closed -$206K – 199
2022
Q3 		$206K Buy
839
+58
+7% +$17.7K 0.03% 187
2022
Q2 		$236K Buy
781
+35
+5% +$11.4K 0.03% 166
2022
Q1 		$306K Buy
746
+29
+4% +$11.4K 0.04% 161
2021
Q4 		$336K Hold
717
– – 0.04% 161
2021
Q3 		$304K Buy
+717
New +$302K 0.04% 160
2018
Q3 		– Sell
-215
Closed -$21K – 113
2018
Q2 		$21K Buy
+215
New +$19.8K 0.01% 90

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

Trust Asset Management's WST Position: Q2 2026 in Review

Trust Asset Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 805 shares worth $289K. The position accounts for 0.02% of the portfolio, ranked #201.

Trust Asset Management first reported a position in WST in Q2 2018 and has held it in 18 quarters since. The position peaked at $338K in Q1 2024. 142 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Trust Asset Management held 805 shares of West Pharmaceutical worth $289K as of Q2 2026.
  • Trust Asset Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.02% of Trust Asset Management's portfolio in Q2 2026, its #201 holding.
  • Trust Asset Management first reported a position in West Pharmaceutical in Q2 2018 and has held it in 18 quarters since.
  • Trust Asset Management's West Pharmaceutical position peaked at $338K in Q1 2024.
  • 142 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.